HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
₹1,768.30
Day range
₹1,772.60 - ₹1,808.10
Year range
₹1,021.80 - ₹1,910.00
Market cap
244.64B INR
Avg Volume
300.80K
P/E ratio
69.53
Dividend yield
0.41%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.03B | 28.38% |
Operating expense | 3.38B | 6.85% |
Net income | 934.50M | 31.57% |
Net profit margin | 13.30 | 2.47% |
Earnings per share | 6.89 | 32.25% |
EBITDA | 2.51B | 80.85% |
Effective tax rate | 20.51% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.05B | -84.65% |
Total assets | 70.33B | -0.10% |
Total liabilities | 37.61B | -1.49% |
Total equity | 32.72B | — |
Shares outstanding | 136.16M | — |
Price to book | 8.44 | — |
Return on assets | — | — |
Return on capital | 7.52% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 934.50M | 31.57% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,354
